Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Shield Thera (STX) Share Price

Price 10.25p on 09-02-2026 at 14:10:13
Change 0.65p 6.77%
Buy 10.50p
Sell 10.00p
Last Trade: Sell 56,000.00 at 10.126p
Day's Volume: 2,003,072
Last Close: 9.60p
Open: 10.50p
ISIN: GB00BYV81293
Day's Range 10.10p - 10.25p
52wk Range: 2.20p - 12.35p
Market Capitalisation: £109.47m
VWAP: 10.22659p
Shares in Issue: 1.07b

Shield Thera (STX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 56,000 10.126p Ordinary
14:02:20 - 09-Feb-26
Sell* 80,000 10.10p Uncrossing Trade
14:00:18 - 09-Feb-26
Sell* 4,938 10.126p Ordinary
12:57:23 - 09-Feb-26
Unknown* 241,080 10.37p Ordinary
12:56:35 - 09-Feb-26
Buy* 9,401 10.50p Ordinary
12:55:12 - 09-Feb-26
Sell* 60 10.00p SI Trade
12:55:11 - 09-Feb-26
Buy* 9,821 10.50p SI Trade
12:55:11 - 09-Feb-26
Buy* 18,000 10.20p Ordinary
12:47:38 - 09-Feb-26
Unknown* 20,000 10.00p Ordinary
12:42:15 - 09-Feb-26
Unknown* 2,960 10.00p Ordinary
12:37:36 - 09-Feb-26
See more Shield Thera trades

Shield Thera (STX) Share Price History

Time period:
to
Date Open High Low Close Volume
9th Feb 2026 (Mon) 10.50 11.00 10.10 11.00 2,472,300
6th Feb 2026 (Fri) 10.00 10.00 9.25 9.60 1,944,396
5th Feb 2026 (Thu) 10.10 10.25 10.00 10.00 606,645
4th Feb 2026 (Wed) 10.25 10.25 10.25 10.25 3,218,146
3rd Feb 2026 (Tue) 10.875 10.875 10.20 10.25 2,224,470
2nd Feb 2026 (Mon) 10.55 10.875 10.55 10.875 1,638,229
30th Jan 2026 (Fri) 11.75 11.75 10.75 10.75 2,181,730
29th Jan 2026 (Thu) 10.35 11.00 11.00 11.00 3,828,674
28th Jan 2026 (Wed) 9.90 10.35 10.35 10.35 1,270,586
27th Jan 2026 (Tue) 10.10 10.10 9.50 9.90 1,891,908
26th Jan 2026 (Mon) 10.75 10.75 9.25 10.10 5,330,298
23rd Jan 2026 (Fri) 10.75 10.75 10.50 10.75 1,010,831
22nd Jan 2026 (Thu) 10.50 10.75 10.50 10.75 1,084,324
21st Jan 2026 (Wed) 12.20 12.20 10.70 10.70 4,814,504
20th Jan 2026 (Tue) 11.25 11.25 10.75 11.25 2,346,755
19th Jan 2026 (Mon) 12.15 11.50 11.20 11.25 2,294,458
16th Jan 2026 (Fri) 12.15 12.20 12.20 12.20 1,258,025
15th Jan 2026 (Thu) 11.75 12.20 11.75 12.15 1,357,703
14th Jan 2026 (Wed) 11.25 11.75 11.25 11.75 3,427,579
13th Jan 2026 (Tue) 10.75 11.25 10.75 11.25 1,696,583
12th Jan 2026 (Mon) 10.50 10.75 10.50 10.75 1,380,565
9th Jan 2026 (Fri) 10.00 10.50 10.00 10.50 1,821,641
See more Shield Thera price history

Shield Thera (STX) Regulatory News

Date Source Headline
30th Jan 2026 7:05 am RNS Total Voting Rights
30th Jan 2026 7:00 am RNS Approval for ACCRUFeR in China expected in Q1 2026
21st Jan 2026 7:00 am RNS Q4 2025 Trading Update
2nd Jan 2026 11:06 am RNS Block listing 6 Monthly Return
2nd Jan 2026 7:00 am RNS Total Voting Rights
2nd Jan 2026 7:00 am RNS Total Voting Rights
22nd Dec 2025 7:00 am RNS FDA approves extension for ACCRUFeR®
22nd Dec 2025 7:00 am RNS FDA approves extension for ACCRUFeR®
18th Dec 2025 7:13 am RNS Block Listing Application
11th Dec 2025 7:00 am RNS-R Shield Wins Gold at Titan Branding Awards
See more Shield Thera regulatory news

Shield Thera (STX) Share News

IN BRIEF: Shield Therapeutics gets three more years of US exclusivity

9th Feb 2026 11:20

Shield Therapeutics PLC - Newcastle, England-based commercial-stage pharmaceutical company - Says the US Food & Drug Administration grants an additional three years of data exclusivity for Accrufer. The exclusivity remains in place until December 19, 2028, in addition to the Accrufer/Feraccru patent coverage valid until the mid-2030s. Read More

EARNINGS AND TRADING: Peel Hunt upbeat; Transense cuts profit outlook

30th Jan 2026 16:12

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

Shield Therapeutics reaches cash flow positivity as revenue grows

21st Jan 2026 16:24

(Alliance News) - Shield Therapeutics PLC on Wednesday said it achieved operating cash flow positivity in the fourth quarter of 2025, as it guided an operating profit in 2026. Read More

EARNINGS AND TRADING: Corel loss widens; Christie sells Vennersys

22nd Dec 2025 15:38

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

Shield Therapeutics upbeat as Accrufer trial initiated in Japan

14th Nov 2025 12:08

(Alliance News) - Shield Therapeutics PLC on Friday reported the commencement of a phase two Accrufer trial in Japan for the treatment of pulmonary arterial hypertension. Read More

See more Shield Thera news
FTSE 100 Latest
Value10,333.98
Change-35.77

Login to your account

Forgot Password?

Not Registered